All News

Today is April 10, 2021. All times in Eastern Daylight Time.

GlycoMimetics to Present at AACR 2021 Meeting on Positive Therapeutic Effects of GMI-1757 in a Pancreatic Adenocarcinoma Model

04/10/2021 - 09:00 AM

BUSINESS WIRE
Positive Findings From Phase 1b Trial of GlycoMimetics’ GMI-1359 To Be Presented at AACR 2021 Meeting

04/10/2021 - 09:00 AM

BUSINESS WIRE
Ultimovacs Presents the INITIUM Study Design as a Trial-in-Progress Poster at AACR Annual Meeting 2021

04/10/2021 - 08:35 AM

BUSINESS WIRE
Data at AACR Demonstrate Growing Clinical Utility of Guardant Health Liquid Biopsies in the Treatment and Management of Advanced Cancers

04/10/2021 - 08:35 AM

BUSINESS WIRE
Investigational Combination of Aliqopa® (copanlisib) and rituximab Significantly Increases Progression-Free Survival in Patients with Relapsed Indolent non-Hodgkin's Lymphoma

04/10/2021 - 08:33 AM

BUSINESS WIRE
Arcus Biosciences Presents Updated Data for Etrumadenant in Third-Line Metastatic Colorectal Cancer and New Data on its HIF-2α Program at the AACR 2021 Annual Meeting

04/10/2021 - 08:33 AM

BUSINESS WIRE
OncoMyx Presents at AACR First Data Showing Multi-Armed Myxoma Virotherapy Can Modulate Anti-Tumor Immune Response

04/10/2021 - 08:30 AM

BUSINESS WIRE
SQZ Biotech Presents Preclinical Data on its mRNA-based enhanced APCs and the Potential of the SQZ APC Platform in KRAS Driven Tumors

04/10/2021 - 08:30 AM

BUSINESS WIRE
Neoadjuvant Opdivo (nivolumab) Plus Chemotherapy Significantly Improves Pathologic Complete Response in Patients with Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate -816 Trial

04/10/2021 - 08:30 AM

BUSINESS WIRE
Boundless Bio Presents Data on the Role of Extrachromosomal DNA (ecDNA) in Mediating Resistance to Targeted Therapies at the American Association for Cancer Research (AACR) Annual Meeting 2021

04/10/2021 - 08:30 AM

BUSINESS WIRE
Tachyon Presents Promising Preclinical Data on Its First-in-class Pan-KDM4 Epigenetic Regulator, TACH101

04/10/2021 - 08:30 AM

BUSINESS WIRE
ITM Presents Design for Ongoing Phase III COMPETE Trial with n.c.a. 177Lu-Edotreotide at AACR Annual Meeting 2021

04/10/2021 - 08:30 AM

BUSINESS WIRE
Clovis Oncology Highlights Rubraca® (rucaparib) Clinical Data at AACR Virtual Annual Meeting 2021

04/10/2021 - 08:30 AM

BUSINESS WIRE
ImmunoGen Presents Preclinical Data on IMGC936 at the AACR Virtual Annual Meeting

04/10/2021 - 08:30 AM

BUSINESS WIRE
Scholar Rock Presents Biomarker Strategy to Support the SRK-181 DRAGON Phase 1 Proof-of-Concept Trial at the American Association for Cancer Research Annual Meeting

04/10/2021 - 08:30 AM

BUSINESS WIRE
Spectrum Pharmaceuticals Presents Additional Twice Daily Dosing Data for Poziotinib at the AACR Virtual Meeting 2021

04/10/2021 - 08:30 AM

BUSINESS WIRE
Kezar Life Sciences Presents Preclinical Data with IND Candidate KZR-261 at American Association for Cancer Research (AACR) 2021 Virtual Annual Meeting

04/10/2021 - 08:30 AM

BUSINESS WIRE
Immune-Onc Therapeutics Announces First Public Presentation of Data for its Myeloid Checkpoint Inhibitor, IO-202, in Solid Tumors at AACR21

04/10/2021 - 08:30 AM

BUSINESS WIRE
Biodesix Releases New Data at AACR on Proteomic Profiling to Help Guide Physician Treatment Strategies for NSCLC Patients

04/10/2021 - 08:30 AM

BUSINESS WIRE
Xencor Presents Data from Multiple Preclinical XmAb® Bispecific Antibody and Cytokine Programs at the AACR Annual Meeting 2021

04/10/2021 - 08:30 AM

BUSINESS WIRE
Freenome Presents Data Revealing Signatures of Immune Checkpoint Inhibitor Treatment Response Found to Be Common Across Kidney, Melanoma, and Lung Cancers

04/10/2021 - 08:30 AM

BUSINESS WIRE
Zymeworks Showcases Preclinical Assets, Including New Therapeutic Platform, ProTECT™, and Zanidatamab Mechanisms of Action at AACR Annual Meeting

04/10/2021 - 08:30 AM

BUSINESS WIRE
Bicycle Therapeutics Announces Presentations at the AACR Annual Meeting 2021

04/10/2021 - 08:30 AM

BUSINESS WIRE
Synthekine Presents Data at AACR Annual Meeting 2021 Demonstrating Selective IL-2 Partial Agonist, STK-012, Promotes Anti-Tumor Response without Related Toxicities

04/10/2021 - 08:30 AM

BUSINESS WIRE
Tallac Therapeutics Presents New Data on Toll-like Receptor Agonist Antibody Conjugate, TAC-001, at the 2021 Virtual Annual Meeting of the American Association for Cancer Research (AACR)

04/10/2021 - 08:00 AM

BUSINESS WIRE

1 2 3 4 5 6 7 8 9 10 11 ... 678

Next »

Search